💡 Bottom Line
Mounjaro and Zepbound are the same drug (tirzepatide) by Eli Lilly. Mounjaro is approved for diabetes with broader insurance coverage. Zepbound is approved for weight loss with LillyDirect self-pay starting at $299/month. If you have diabetes, Mounjaro may be your cheapest path to tirzepatide.

If you've been comparing tirzepatide prices, you've probably noticed two brand names: Mounjaro (for diabetes) and Zepbound (for weight loss). They're the same molecule, the same doses, the same injection — just different labels and different insurance treatment.

Price Comparison

Pricing PathwayMounjaro (Diabetes)Zepbound (Weight Loss)
List price$1,023/mo$1,059/mo
LillyDirect vials self-payNot available$299–449/mo
LillyDirect KwikPenNot available$299–449/mo
Insurance for diabetesBroadly coveredNot indicated
Insurance for weight lossOff-label (rare)~40% of plans
Medicare Bridge (July 2026+)Covered for diabetes$50/mo (KwikPen only)
Commercial savings cardAs low as $25/moAs low as $25/mo

The Strategic Choice

If you have type 2 diabetes: ask your doctor about Mounjaro. Insurance coverage for diabetes is significantly broader, and with a savings card, your copay could be as low as $25/month.

If you don't have diabetes: Zepbound through LillyDirect starts at $299/month, or compounded tirzepatide starts at $179/month.

ProviderStarting PriceDetails
Yucca Health$149/moCheck Price → Paid link
Novi$174/moCheck Price → Paid link
Synergy Rx$199/moCheck Price → Paid link

Key Takeaways

Compare All GLP-1 Prices

See today's lowest verified prices from vetted telehealth providers.

Compare Prices →
Paid link · Compounded medications are not FDA-approved.